UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002941
Receipt number R000003577
Scientific Title The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B
Date of disclosure of the study information 2009/12/25
Last modified on 2011/10/31 09:52:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B

Acronym

The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B

Scientific Title

The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B

Scientific Title:Acronym

The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B

Region

Japan


Condition

Condition

The patients of GERD with chronic liver disease

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The improvement of QOL with GERD and chronic liver disease after the treatment of PPI or H2-B

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

The symptons of upper gastrointestine evaluated by F-sacle

Key secondary outcomes

The symptons by SF-8
gastrointesitinal peptide


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

sodium rabeprazole

Interventions/Control_2

ranitidine hydrochloride

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients evaluated by F-scale
The patients evaluated by SF-8
The patients without gastric ulcer or duodenal ulcer
The patients with chronic liver disease

Key exclusion criteria

The patients with allergy for sodium rabeprazole and ranitidine hydrochloride
The patients with severe live failure
The patients treated by Interferon or with malignant tumor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name MAKOTO ARAI

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba City

TEL

043-226-2083

Email



Public contact

Name of contact person

1st name
Middle name
Last name MAKOTO ARAI

Organization

CHiba University Hospital

Division name

Gastroenterology

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

CHiba University hospital

Institute

Department

Personal name



Funding Source

Organization

Chiba University hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

千葉大学病院


Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 12 Month 25 Day

Last modified on

2011 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003577


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name